Deliargyris Efthymios

Deliargyris Efthymios is listed in filings as Chief Medical Officer at Cytosorbents Corporation. This profile follows SEC Form 4 activity through Aug 8, 2025, including 6 public disclosures. Recent filings connect the profile to Cytosorbents Corporation (CTSO). The current snapshot covers public activity from Oct 8, 2024 to Aug 8, 2025. Reported amounts are shown as $95.0K to $119.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.